Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial

Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Glossary display added and metadata updates including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T22:00:46.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    23 days ago
    Change Detected
    Summary
    - Page revision updated from v3.3.3 to v3.3.4. This is a metadata/maintenance change with no visible impact on study content.
    Difference
    0.1%
    Check dated 2026-01-14T03:24:35.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing California, Florida, Illinois, Massachusetts, New York, Pennsylvania, and Texas, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T20:38:56.000Z thumbnail image
  5. Check
    72 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:25:17.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page. It previously served as a status banner and did not affect the study details.
    Difference
    0.4%
    Check dated 2025-11-18T06:49:39.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    An updated 'Last Update Posted' timestamp and minor layout adjustments are present. Core study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T20:39:42.000Z thumbnail image

Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.